Informational content of official pharmaceutical industry web sites about treatments for erectile dysfunction - PubMed (original) (raw)
. 2004 Dec;38(12):2029-34.
doi: 10.1345/aph.1E251. Epub 2004 Oct 26.
Affiliations
- PMID: 15507499
- DOI: 10.1345/aph.1E251
Informational content of official pharmaceutical industry web sites about treatments for erectile dysfunction
Katherine E Waack et al. Ann Pharmacother. 2004 Dec.
Abstract
Background: In the last 5 years, several treatments have become available for erectile dysfunction (ED). During this same period, consumer use of the Internet for health information has increased rapidly. In traditional direct-to-consumer advertisements, viewers are often referred to a pharmaceutical company Web site for further information.
Objective: To evaluate the accessibility and informational content of 5 pharmaceutical company Web sites about ED treatments.
Methods: Using 10 popular search engines and 1 specialized search engine, the accessibility of the official pharmaceutical company-sponsored Web site was determined by searching under brand and generic names. One company also manufactures an ED device; this site was also included. A structured, explicit review of information found on these sites was conducted.
Results: Of 110 searches (1 for each treatment, including corresponding generic drug name, using each search engine), 68 yielded the official pharmaceutical company Web site within the first 10 links. Removal of outliers (for both brand and generic name searches) resulted in 68 of 77 searches producing the pharmaceutical company Web site for the brand-name drug in the top 10 links. Although all pharmaceutical company Web sites contained general information on adverse effects and contraindications to use, only 2 sites gave actual percentages. Three sites provided references for their materials or discussed other treatment or drug options, while 4 of the sites contained profound advertising or emotive content. None mentioned cost of the therapy.
Conclusions: The information contained on pharmaceutical company Web sites for ED treatments is superficial and aimed primarily at consumers. It is largely promotional and provides only limited information needed to effectively compare treatment options.
Similar articles
- Pharmaceutical company internet sites as sources of information about antidepressant medications.
Graber MA, Weckmann M. Graber MA, et al. CNS Drugs. 2002;16(6):419-23. doi: 10.2165/00023210-200216060-00005. CNS Drugs. 2002. PMID: 12027787 - The sources and popularity of online drug information: an analysis of top search engine results and web page views.
Law MR, Mintzes B, Morgan SG. Law MR, et al. Ann Pharmacother. 2011 Mar;45(3):350-6. doi: 10.1345/aph.1P572. Epub 2011 Feb 22. Ann Pharmacother. 2011. PMID: 21343404 - Evaluation of the quality and accuracy of information regarding aromatase inhibitors available on the internet.
Beaton C, Codd RJ, Holland PA, Gateley CA. Beaton C, et al. Breast J. 2008 Jul-Aug;14(4):366-8. doi: 10.1111/j.1524-4741.2008.00599.x. Breast J. 2008. PMID: 18537915 - Navigating the World Wide Web in search of resources on antimicrobial resistance.
Harbarth S, Emonet S. Harbarth S, et al. Clin Infect Dis. 2006 Jul 1;43(1):72-8. doi: 10.1086/504877. Epub 2006 May 24. Clin Infect Dis. 2006. PMID: 16758421 Review. - Pathology in the era of Web 2.0.
Schreiber WE, Giustini DM. Schreiber WE, et al. Am J Clin Pathol. 2009 Dec;132(6):824-8. doi: 10.1309/AJCPEC9FZSB4DEDH. Am J Clin Pathol. 2009. PMID: 19926572 Review.
Cited by
- Direct-to-Consumer Drug Advertisement and Prescribing Practices: Evidence Review and Practical Guidance for Clinicians.
Franquiz MJ, McGuire AL. Franquiz MJ, et al. J Gen Intern Med. 2021 May;36(5):1390-1394. doi: 10.1007/s11606-020-06218-x. Epub 2020 Sep 15. J Gen Intern Med. 2021. PMID: 32930939 Free PMC article. Review. - Quality and benefits of the erectile dysfunction information on websites, social-media, and applications.
Russo GI, Asmundo MG, Durukan E, Fode M. Russo GI, et al. Int J Impot Res. 2024 Nov;36(7):688-692. doi: 10.1038/s41443-023-00725-1. Epub 2023 Jun 27. Int J Impot Res. 2024. PMID: 37369784 Review. - Pharma Websites and "Professionals-Only" Information: The Implications for Patient Trust and Autonomy.
Graber MA, Hershkop E, Graber RI. Graber MA, et al. J Med Internet Res. 2017 May 24;19(5):e178. doi: 10.2196/jmir.7164. J Med Internet Res. 2017. PMID: 28539303 Free PMC article. - What are the public health effects of direct-to-consumer drug advertising?
Almasi EA, Stafford RS, Kravitz RL, Mansfield PR. Almasi EA, et al. PLoS Med. 2006 Mar;3(3):e145. doi: 10.1371/journal.pmed.0030145. Epub 2006 Mar 28. PLoS Med. 2006. PMID: 16563041 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical